Literature DB >> 29567536

Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals.

Baskaran Rathinasamy1, Bharath Kumar Velmurugan2.   

Abstract

Long non coding RNAs (lncRNAs) are involved in modulating the expression of other non-coding RNAs (ncRNA), such as microRNAs, or target proteins through the epigenetic, transcriptional, or post-transcriptional regulations. Genomic mutations in cancer reside inside regions that do not code for proteins and these regions are often transcribed into long non coding RNAs (lncRNAs). Emerging evidences have revealed an intense involvement of lncRNAs in the cancer development and progression. Recently, emerging evidences have depicted that the phytochemicals interact with lncRNAs to modulate their activities. Such findings are highly important for the identification of therapeutic strategies against diseases that are particularly associated with an aberrant lncRNA signaling. This review aims at deciphering the role of lncRNAs in the cancer development and progression, and their regulation by various phytochemicals.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Phytochemicals; lncRNA; miRNA; ncRNA

Mesh:

Substances:

Year:  2018        PMID: 29567536     DOI: 10.1016/j.biopha.2018.03.077

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

1.  Role of Curcumin in Regulating Long Noncoding RNA Expression in Cancer.

Authors:  Abolfazl Amini; Parand Khadivar; Ali Ahmadnia; Morteza Alipour; Muhammed Majeed; Tannaz Jamialahmadi; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review.

Authors:  Samantha Goodman; Grace Chappell; Kathryn Z Guyton; Igor P Pogribny; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2021-12-09       Impact factor: 7.015

Review 3.  The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer.

Authors:  Hangsheng Zhou; Hongyuan Wan; Yanyan Feng; Lijie Zhu; Yuanyuan Mi
Journal:  Clin Transl Oncol       Date:  2022-10-20       Impact factor: 3.340

4.  Association of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cells.

Authors:  Qian Chen; Sijia Jiang; Haihua Liu; Yue Gao; Xiaoxue Yang; Zhonglu Ren; Yunfei Gao; Lu Xiao; Haoyue Hu; Yanhong Yu; Xinping Yang; Mei Zhong
Journal:  Cell Death Dis       Date:  2020-07-27       Impact factor: 8.469

Review 5.  Long noncoding RNAs and their link to cancer.

Authors:  Justine M Grixti; Duncan Ayers
Journal:  Noncoding RNA Res       Date:  2020-05-13

6.  Prognostic and clinicopathological significance of long non-coding RNA UCA1 in colorectal cancer: Results from a meta-analysis.

Authors:  Xiaoqun Liu; Xiangdong Liu; Tiankui Qiao; Wei Chen
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Long non‑coding RNA ZEB2‑AS1 affects cell proliferation and apoptosis via the miR‑122‑5p/PLK1 axis in acute myeloid leukemia.

Authors:  Jianmin Guan; Ping Liu; Aixia Wang; Bo Wang
Journal:  Int J Mol Med       Date:  2020-07-23       Impact factor: 4.101

8.  Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p.

Authors:  Guojie Lu; Yaosen Zhang
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

Review 9.  Long Non-Coding RNA Associated with Cholesterol Homeostasis and Its Involvement in Metabolic Diseases.

Authors:  Kang-Hoon Lee; Hyeon-Ji Hwang; Je-Yoel Cho
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

10.  Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis.

Authors:  Weiwei Chen; Yuting Li; Liliangzi Guo; Chenxing Zhang; Shaohui Tang
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.